You are on page 1of 2

29.11.

2022

Dear Dr,

DNA isolation was performed from the peripheral blood sample of your patient Ersen
Spahija. The DNA sample was transferred to the laboratory of our partner Neuberg Genomic
Medicine Center in the United States and analyzed by whole exome sequencing-WES with NGS
method.

A total of 9 GB of data was created and bioinformatics analysis was performed by sequencing
8 genes that may be related to clinical data with 100% coverage. In the HFE gene responsible for
hemochromatosis, 1 'pathogenic' and 1 'likely benign' variant was detected in heterozygous form.
Almost all of the kits available in the market for hemochromatosis disease target the p.H63D,
p.C282Y and p.S65C pathogenic variants that are frequently detected in patients. For this reason,
there are cases that have clinical data using real-time PCR-based kits in the past years, but only one
of these 3 variants was found to be heterozygous, and the situation could not be clarified genetically.
If studied by sequencing, there is the possibility of detecting an additional heterozygous variant as in
this case.
Pathogenic c.187 C>G (p.His63Asp, p.H63D) variant was found heterozygous in your patient
and a second variant c.340+4 T>C heterozygote was detected. This variant (rs2071303) is registered
as 'likely benign' in the ClinVar database. There are also studies reporting polymorphism (de Lucas AP
et al 2005, PMID: 2071303). c.340+4 T>C is a splice site variant. Removal of exon 2 by mis-splicing can
result in a protein missing the alpha 1 domain, which is required for HFE/transferrin receptor-1
interactions. Branco CC et al (2015, PMID: 26501199) found that heterozygous c.340+4 T>C variant
(positive in 74.3% of patients) was transmitted together with heterozygous c.187 C>G (p.His63Asp,
p.H63D) in patients with Hemochromatosis on the island of Sao Miguel. They reported iron
accumulation. The last sentence of the published study is 'this data needs to be verified in other
societies'. Six months ago, we obtained the same result as your patient in a 34-year-old male Turkish
patient with similar clinical data.

1
In conclusion, the two heterozygous HFE variants detected explain the iron accumulation. I got
permission for the article from the Turkish patient. If your patient's approval and permission are
obtained, the publication of the data that the c.340+4 T>C variant, which is registered as 'likely benign' in
the database, creates iron accumulation when co-existing with p.His63Asp will be illuminating for cases
where the same alleles are detected in the future.

Sincerely

Prof.Dr.Veysel Sabri Hançer


Scientific Director
Pentagene Genetics ShPK

You might also like